THERESA CALLENDER: Open Payments
NPI 1962410860 · BRUNSWICK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 8 payments from 5 companies in 2025. Trend: 2023 $530 · 2024 $356 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
Products named: INGREZZA, CAPLYTA, Auvelity, FANAPT, REJOYN.
Industry payments across ME — which companies pay providers there.
